Amprius Technologies, Inc. (NYSE:AMPX) Given Average Recommendation of "Moderate Buy" by Brokerages

Key Points

• Analyst consensus: Nine brokers rate Amprius as a Moderate Buy with an average 12‑month target of $19.75, and several firms recently raised targets (B. Riley $22, Craig Hallum $21, Needham and Roth $20).
• Insider selling: Company insiders have sold 2,929,357 shares worth about $37.8M in the past 90 days (including recent sales by the CTO and a director), though insiders still own 12.9% of the stock.
• Financials: Q4 beat estimates—EPS of ($0.01) vs. ($0.04) expected and revenue $25.23M vs. $22.91M—but Amprius remains unprofitable (net margin -60.3%) with FY2026 guidance of -0.06 EPS and analyst expectations of -0.45 EPS for the current fiscal year.

Shares of Amprius Technologies, Inc. (NYSE:AMPX - Get Free Report) have earned a consensus rating of "Moderate Buy" from the nine ratings firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation and eight have issued a buy recommendation on the company. The average twelve-month target price among brokers that have covered the stock in the last year is $19.75.

AMPX has been the subject of several research reports. B. Riley Financial boosted their price objective on Amprius Technologies from $16.00 to $22.00 and gave the stock a "buy" rating in a research note on Monday, March 9th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Amprius Technologies in a research note on Wednesday, January 21st. Craig Hallum boosted their price target on Amprius Technologies from $17.00 to $21.00 and gave the stock a "buy" rating in a research report on Friday, March 6th. Needham & Company LLC reissued a "buy" rating and issued a $20.00 price objective on shares of Amprius Technologies in a research note on Tuesday, March 10th. Finally, Roth Mkm restated a "buy" rating and issued a $20.00 price objective (up from $16.00) on shares of Amprius Technologies in a report on Friday, March 6th.

Insider Buying and Selling at Amprius Technologies

In other news, CTO Constantin Ionel Stefan sold 25,366 shares of the firm's stock in a transaction dated Monday, February 23rd. The shares were sold at an average price of $10.16, for a total value of $257,718.56. Following the transaction, the chief technology officer directly owned 723,330 shares of the company's stock, valued at approximately $7,349,032.80. This trade represents a 3.39% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Kang Sun sold 61,251 shares of the business's stock in a transaction dated Monday, February 23rd. The stock was sold at an average price of $10.16, for a total transaction of $622,310.16. Following the transaction, the director owned 1,342,400 shares in the company, valued at $13,638,784. The trade was a 4.36% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 2,929,357 shares of company stock valued at $37,783,110 over the last ninety days. 12.90% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. increased its holdings in shares of Amprius Technologies by 9.5% in the fourth quarter. Vanguard Group Inc. now owns 7,128,657 shares of the company's stock valued at $56,245,000 after purchasing an additional 616,037 shares during the last quarter. Geode Capital Management LLC lifted its position in Amprius Technologies by 10.5% during the fourth quarter. Geode Capital Management LLC now owns 2,678,417 shares of the company's stock worth $21,137,000 after buying an additional 253,529 shares in the last quarter. State Street Corp boosted its stake in Amprius Technologies by 16.6% during the fourth quarter. State Street Corp now owns 2,553,710 shares of the company's stock worth $20,149,000 after buying an additional 363,928 shares during the last quarter. Invesco Ltd. grew its holdings in Amprius Technologies by 113.3% in the 3rd quarter. Invesco Ltd. now owns 2,379,384 shares of the company's stock valued at $25,031,000 after buying an additional 1,263,846 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its holdings in Amprius Technologies by 23.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 2,194,841 shares of the company's stock valued at $17,317,000 after buying an additional 410,724 shares in the last quarter. 5.04% of the stock is currently owned by institutional investors and hedge funds.

Amprius Technologies Stock Down 5.0%

Shares of NYSE AMPX opened at $18.15 on Friday. The firm has a market cap of $2.49 billion, a price-to-earnings ratio of -53.39 and a beta of 3.04. The company's 50-day simple moving average is $12.84 and its 200-day simple moving average is $11.50. Amprius Technologies has a 52-week low of $1.97 and a 52-week high of $19.76.

Amprius Technologies (NYSE:AMPX - Get Free Report) last released its quarterly earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.03. The firm had revenue of $25.23 million during the quarter, compared to the consensus estimate of $22.91 million. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 24.29%. Amprius Technologies has set its FY 2026 guidance at --0.060 EPS. Equities research analysts anticipate that Amprius Technologies will post -0.45 EPS for the current fiscal year.

Amprius Technologies Company Profile

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.